Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Welch

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Lancet (London, England)|August 23, 2005
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysesMontserrat García-Closas, Núria Malats, Debra Silverman, et al.
Infectious Diseases and Therapy|March 28, 2019
Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureusKimberly C Claeys, Evan J Zasowski, Trang D Trinh, et al.
Nature Medicine|January 3, 2025
International multicenter validation of AI-driven ultrasound detection of ovarian cancerFilip Christiansen, Emir Konuk, Adithya Raju Ganeshan, et al.
Nature Genetics|May 29, 2007
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerDavid J Hunter, Peter Kraft, Kevin B Jacobs, et al.
Nature Genetics|April 3, 2007
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24Meredith Yeager, Nick Orr, Richard B Hayes, et al.
Nature Genetics|February 12, 2008
Multiple loci identified in a genome-wide association study of prostate cancerGilles Thomas, Kevin B Jacobs, Meredith Yeager, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Lancet (London, England)|August 23, 2005
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysesMontserrat García-Closas, Núria Malats, Debra Silverman, et al.
Infectious Diseases and Therapy|March 28, 2019
Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureusKimberly C Claeys, Evan J Zasowski, Trang D Trinh, et al.
Nature Medicine|January 3, 2025
International multicenter validation of AI-driven ultrasound detection of ovarian cancerFilip Christiansen, Emir Konuk, Adithya Raju Ganeshan, et al.
Nature Genetics|May 29, 2007
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerDavid J Hunter, Peter Kraft, Kevin B Jacobs, et al.
Nature Genetics|April 3, 2007
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24Meredith Yeager, Nick Orr, Richard B Hayes, et al.
Nature Genetics|February 12, 2008
Multiple loci identified in a genome-wide association study of prostate cancerGilles Thomas, Kevin B Jacobs, Meredith Yeager, et al.
Pageof 11